Baxter (NYSE:BAX) reported Q2 EPS of $0.87, in-line with the analyst estimate of $0.87. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.88 billion.
GUIDANCE:
Baxter sees FY2022 EPS of $3.60-$3.70, versus the consensus of $4.13.